Finance

Beta
Lists
603707:SHA
Nanjing King-Frind Bchmcl Phrmctcl C Ltd
CNÂ¥8.04
+1.39%
(+0.11) 1D
Jun 5, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603707...
Open
CNÂ¥8.00
High
CNÂ¥8.10
Low
CNÂ¥7.96
Mkt. cap
12.99B
Avg. vol.
9.02M
Volume
6.05M
Dividend
1.24%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 7, 2023
P/E ratio
22.49
52-wk high
CNÂ¥12.27
52-wk low
CNÂ¥7.89
EPS
CNÂ¥0.36
Shares outstanding
550.55M
No. of employees
2K
Open
CNÂ¥8.00
High
CNÂ¥8.10
Low
CNÂ¥7.96
Mkt. cap
12.99B
Avg. vol.
9.02M
Volume
6.05M
Dividend
1.24%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 7, 2023
P/E ratio
22.49
52-wk high
CNÂ¥12.27
52-wk low
CNÂ¥7.89
EPS
CNÂ¥0.36
Shares outstanding
550.55M
No. of employees
2K
News stories
From sources across the web
About Nanjing King-Frind Bchmcl Phrmctcl C Ltd
CEO-
Employees1.56K
FoundedOct 16, 2000
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.09B
945.90M
1.06B
928.66M
Cost of goods sold
607.60M
582.45M
467.34M
628.62M
Cost of revenue
607.60M
582.45M
467.34M
628.62M
Research and development expenses
72.90M
118.85M
87.13M
32.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
176.61M
153.48M
194.73M
168.47M
Operating expense
266.75M
268.46M
295.74M
198.47M
Total operating expenses
874.35M
850.92M
763.07M
827.09M
Operating income
220.28M
94.98M
301.86M
101.57M
Other non operating income
12.35M
-47.60M
46.27M
-38.15M
EBT including unusual items
217.42M
151.93M
237.33M
97.71M
EBT excluding unusual items
202.94M
69.62M
263.19M
68.83M
Income tax expense
15.87M
8.73M
85.27M
8.69M
Effective tax rate
7.30%
5.75%
35.93%
8.90%
Other operating expenses
12.98M
4.96M
5.89M
-2.84M
Net income
201.55M
143.20M
152.07M
89.01M
Net profit margin
18.41%
15.14%
14.28%
9.58%
Earnings per share
-
-
-
-
Interest and investment income
4.56M
17.23M
12.51M
5.41M
Interest expense
-11.15M
-18.09M
-12.49M
-
Net interest expenses
-6.59M
-859.98K
22.03K
5.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
278.95M
138.02M
361.57M
161.28M
Gain or loss from assets sale
154.67K
-154.67K
3.26M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more